Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Ordinary Shares / American Depositary Shares
-
Shares outstanding
-
384M
-
Number of holders
-
0
-
Total 13F shares, excl. options
-
0
-
Shares change
-
-4.22M
-
Total reported value, excl. options
-
$0
-
Value change
-
-$4.89M
-
Number of sells
-
-13
Significant Holders of Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB) as of Q3 2025
13 filings reported holding CMMB - Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares as of Q3 2025.
Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB) has 0 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 0 shares
of 384M outstanding shares and own 0% of the company stock.
Largest 10 shareholders include GAMMA Investing LLC (0 shares), Yelin Lapidot Holdings Management Ltd. (0 shares), SBI Securities Co., Ltd. (0 shares), RHUMBLINE ADVISERS (0 shares), JPMORGAN CHASE & CO (0 shares), UBS Group AG (0 shares), MORGAN STANLEY (0 shares), ORBIMED ADVISORS LLC (0 shares), SPHERA FUNDS MANAGEMENT LTD. (0 shares), and BOOTHBAY FUND MANAGEMENT, LLC (0 shares).
This table shows the top 0 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.